| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US706187A | 1987-01-27 | 1987-01-27 | |
| US7061 | 1987-01-27 |
| Publication Number | Publication Date |
|---|---|
| EP0276807A2 EP0276807A2 (en) | 1988-08-03 |
| EP0276807A3true EP0276807A3 (en) | 1988-10-12 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP88101071AWithdrawnEP0276807A3 (en) | 1987-01-27 | 1988-01-26 | Lipid regulating compositions |
| Country | Link |
|---|---|
| EP (1) | EP0276807A3 (en) |
| KR (1) | KR890700343A (en) |
| AU (1) | AU1422388A (en) |
| DK (1) | DK536088D0 (en) |
| WO (1) | WO1988005296A2 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4925676A (en)* | 1989-02-02 | 1990-05-15 | Warner-Lambert Company | Extended release gemfibrozil composition |
| US4927639A (en)* | 1989-02-02 | 1990-05-22 | Warner-Lambert Company | Modified release gemfibrozil composition |
| GR1002098B (en)* | 1989-06-08 | 1995-12-28 | Squibb & Sons Inc | Pharmaceutical composition having good stability |
| CA2039763A1 (en)* | 1990-04-30 | 1991-10-31 | Henry Y. Pan | Combination of pravastatin and a fibric acid derivative, and method for treating dyslipidemia using such combination |
| EP0462067A1 (en)* | 1990-06-15 | 1991-12-18 | Warner-Lambert Company | Gemfibrozil formulations |
| DE19858789A1 (en) | 1998-12-18 | 2000-06-21 | Bayer Ag | Medicament combination of cerivastatin and fibrate, has additive effect in the treatment of lipid metabolism disorders, e.g. dyslipidemia or atherosclerosis |
| US6982251B2 (en) | 2000-12-20 | 2006-01-03 | Schering Corporation | Substituted 2-azetidinones useful as hypocholesterolemic agents |
| ATE348649T1 (en) | 2001-01-26 | 2007-01-15 | Schering Corp | COMBINATIONS OF A STEROL ABSORPTION INHIBITOR AND A PPAR ACTIVATOR FOR THE TREATMENT OF CARDIOVASCULAR INDICATIONS |
| PL205343B1 (en) | 2001-01-26 | 2010-04-30 | Schering Corp | The use of substituted azetidinone compounds for the treatment of sitosterolemia |
| US7071181B2 (en) | 2001-01-26 | 2006-07-04 | Schering Corporation | Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors |
| US7053080B2 (en) | 2001-09-21 | 2006-05-30 | Schering Corporation | Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors |
| US7056906B2 (en) | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
| CA2460340C (en) | 2001-09-21 | 2011-02-15 | Schering Corporation | Methods and therapeutic combinations for the treatment of xanthoma using sterol absorption inhibitors |
| AR040588A1 (en) | 2002-07-26 | 2005-04-13 | Schering Corp | PHARMACEUTICAL FORMULATION INCLUDING AN INHIBITOR OF CHOLESTEROL ABSORPTION AND AN INHIBITOR OF A HMGCO TO REDUCTASE |
| CA2504878A1 (en) | 2002-11-06 | 2004-05-27 | Schering Corporation | Cholesterol absorption inhibitors for the treatment of demyelination |
| ES2318274T3 (en) | 2003-03-07 | 2009-05-01 | Schering Corporation | AZETIDINONA SUBSTITUTED COMPOUNDS, FORMULATIONS AND USE OF THE SAME FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA. |
| US7192944B2 (en) | 2003-03-07 | 2007-03-20 | Schering Corp. | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| US7459442B2 (en) | 2003-03-07 | 2008-12-02 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| ES2311806T3 (en) | 2003-03-07 | 2009-02-16 | Schering Corporation | AZETIDINONA COMPOSITE SUBSTITUTED, FORNULATIONS AND USES OF THE SAME FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA. |
| CA2543596A1 (en) | 2003-11-07 | 2005-05-26 | Jj Pharma, Inc. | Hdl-boosting combination therapy complexes |
| GB0427491D0 (en) | 2004-12-16 | 2005-01-19 | Avecia Ltd | Process and compounds |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3674836A (en)* | 1968-05-21 | 1972-07-04 | Parke Davis & Co | 2,2-dimethyl-{11 -aryloxy-alkanoic acids and salts and esters thereof |
| US3846541A (en)* | 1970-10-15 | 1974-11-05 | Pharmacia Ab | Treatment of hypercholesteremia |
| US4049495A (en)* | 1974-06-07 | 1977-09-20 | Sankyo Company Limited | Physiologically active substances and fermentative process for producing the same |
| EP0010299A1 (en)* | 1978-10-19 | 1980-04-30 | Merck & Co. Inc. | Pharmaceutical composition useful for the treatment of hypercholesteremia |
| US4342767A (en)* | 1980-01-23 | 1982-08-03 | Merck & Co., Inc. | Hypocholesteremic fermentation products |
| US4346227A (en)* | 1980-06-06 | 1982-08-24 | Sankyo Company, Limited | ML-236B Derivatives and their preparation |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3674836A (en)* | 1968-05-21 | 1972-07-04 | Parke Davis & Co | 2,2-dimethyl-{11 -aryloxy-alkanoic acids and salts and esters thereof |
| US3846541A (en)* | 1970-10-15 | 1974-11-05 | Pharmacia Ab | Treatment of hypercholesteremia |
| US4049495A (en)* | 1974-06-07 | 1977-09-20 | Sankyo Company Limited | Physiologically active substances and fermentative process for producing the same |
| EP0010299A1 (en)* | 1978-10-19 | 1980-04-30 | Merck & Co. Inc. | Pharmaceutical composition useful for the treatment of hypercholesteremia |
| US4342767A (en)* | 1980-01-23 | 1982-08-03 | Merck & Co., Inc. | Hypocholesteremic fermentation products |
| US4346227A (en)* | 1980-06-06 | 1982-08-24 | Sankyo Company, Limited | ML-236B Derivatives and their preparation |
| Publication number | Publication date |
|---|---|
| AU1422388A (en) | 1988-08-10 |
| KR890700343A (en) | 1989-04-24 |
| WO1988005296A3 (en) | 1988-09-22 |
| DK536088A (en) | 1988-09-27 |
| DK536088D0 (en) | 1988-09-27 |
| EP0276807A2 (en) | 1988-08-03 |
| WO1988005296A2 (en) | 1988-07-28 |
| Publication | Publication Date | Title |
|---|---|---|
| EP0276807A3 (en) | Lipid regulating compositions | |
| EP0433842A3 (en) | 1,2,3-triazole derivatives active as inhibitors of the enzyme hmg-coa reductase and pharmaceutical compositions containing them | |
| EP0352864A3 (en) | Compounds active as inhibitors of the cholesterol biosynthesis | |
| DE3767770D1 (en) | Cholesterin-synthese-hemmer vom typ trans-6-(2-(3- oder 4-carboxamido-substituierte-pyrrol-1-yl)-alkyl)-4-hydroxypyran-2-on. | |
| IL123699A0 (en) | (Methylsulfonyl) phenyl-2-(5H)-furanones as COX-2 inhibitors | |
| AU5786394A (en) | Sulfonate and carbamate derivatives of 3-aroylbenzo(b)thiophenes | |
| NZ225106A (en) | Compositions which include amino acids, metabolites an electrolyte and ribose | |
| JPS549269A (en) | Carboxylic acid esters, process for their preparation and insecticides and miticides containing the same as active constituents | |
| AU8496291A (en) | Flavor composition for pet food | |
| NO882218L (en) | PROCEDURE FOR THE PREPARATION OF PHOSPHORUS HMG-COA REDUCTASE INHIBITORS. | |
| AU8033594A (en) | Aqueous solution inclusion complexes of benzothiophene compounds with water soluble cyclodextrins, and pharmaceutical formulations and methods thereof | |
| WO1998057620A3 (en) | Inositol for modulation of immune response | |
| AU4538489A (en) | Pharmaceutical compositions | |
| AU644458B2 (en) | Novel piperidyl ethers and thioethers as inhibitors of cholesterol biosynthesis | |
| NO882219D0 (en) | PROCEDURE FOR THE PREPARATION OF PHOSPHORUS HMG-COA REDUCTASE INHIBITORS. | |
| AU537173B2 (en) | Stabilization of peroxidase | |
| WO1997008934A3 (en) | Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors | |
| WO1987000751A3 (en) | Use of oxirancarboxylic acids for the treatment of hyperlipemia | |
| AU591476B2 (en) | An n-substituted-phenylteraconimide compound, herbicidal composition, and method for the destruction of undesirable weeds | |
| CA2176655A1 (en) | Stabilized composition of troponin for immunoassays and method of preparation of such a stabilized composition | |
| IE801149L (en) | Trihydroxy-piperidines | |
| IL85189A (en) | Beta-alkyl substituted melatonins,their preparation and pharmaceutical compositions containing them | |
| IE870845L (en) | N'-substituted-n,n'-diacylhydrazines | |
| AU4609693A (en) | An interferon-alpha/beta binding protein its preparation and pharmaceutical compositions containing it | |
| CA2129527A1 (en) | Pharmaceutical composition usable as an analgesic, comprising (r)-(benzoyl-3-phenyl)-2-propionic acid |
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase | Free format text:ORIGINAL CODE: 0009012 | |
| 17P | Request for examination filed | Effective date:19880126 | |
| AK | Designated contracting states | Kind code of ref document:A2 Designated state(s):ES GR | |
| PUAL | Search report despatched | Free format text:ORIGINAL CODE: 0009013 | |
| AK | Designated contracting states | Kind code of ref document:A3 Designated state(s):ES GR | |
| 17Q | First examination report despatched | Effective date:19900216 | |
| STAA | Information on the status of an ep patent application or granted ep patent | Free format text:STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN | |
| 18D | Application deemed to be withdrawn | Effective date:19900801 |